CV Sciences, Inc. financial data

Symbol
CVSI on OTC
Industry
Pharmaceutical Preparations
Location
9530 Padgett Street, Suite 107, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CannaVEST Corp. (to 1/4/2016), Foreclosure Solutions, Inc. (to 11/30/2012)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 112 % -22.4%
Quick Ratio 86.1 % -11.9%
Debt-to-equity 280 % +72.7%
Return On Equity -108 % -234%
Return On Assets -28.4 % -192%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 184M shares +12.9%
Common Stock, Shares, Outstanding 184M shares +14%
Entity Public Float 11M USD +83.3%
Common Stock, Value, Issued 18K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 176M shares +14.1%
Weighted Average Number of Shares Outstanding, Diluted 176M shares +14.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15.7M USD -1.87%
Cost of Revenue 8.54M USD -4.28%
Research and Development Expense 118K USD -21.9%
Operating Income (Loss) -2.19M USD -165%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.4M USD -178%
Income Tax Expense (Benefit) -8K USD -33.3%
Net Income (Loss) Attributable to Parent -2.39M USD -177%
Earnings Per Share, Basic -0.01 USD/shares -150%
Earnings Per Share, Diluted -0.01 USD/shares -150%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 522K USD +21.1%
Inventory, Net 4.9M USD -13.4%
Assets, Current 6.24M USD -21.4%
Property, Plant and Equipment, Net 399K USD +5.28%
Operating Lease, Right-of-Use Asset 94K USD -43.7%
Intangible Assets, Net (Excluding Goodwill) 93K USD +19.2%
Goodwill 971K USD +184%
Other Assets, Noncurrent 127K USD -57.1%
Assets 7.93M USD -13.8%
Accounts Payable, Current 1.93M USD -16.6%
Accrued Liabilities, Current 3.42M USD +0.06%
Liabilities, Current 6.11M USD -0.1%
Deferred Income Tax Liabilities, Net 4K USD -78.9%
Operating Lease, Liability, Noncurrent 19K USD -67.2%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 6.13M USD -2.62%
Accumulated Other Comprehensive Income (Loss), Net of Tax -15K USD -250%
Retained Earnings (Accumulated Deficit) -87M USD -2.83%
Stockholders' Equity Attributable to Parent 1.8M USD -38.2%
Liabilities and Equity 7.93M USD -13.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -518K USD -153%
Net Cash Provided by (Used in) Financing Activities -136K USD +84.4%
Common Stock, Shares Authorized 790M shares 0%
Common Stock, Shares, Issued 184M shares +14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -655K USD -736%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 454K USD -65.5%
Deferred Tax Assets, Valuation Allowance 13.6M USD -19.9%
Deferred Tax Assets, Gross 13.7M USD -20.3%
Operating Lease, Liability 102K USD -45.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.42M USD -178%
Lessee, Operating Lease, Liability, to be Paid 105K USD -47%
Property, Plant and Equipment, Gross 1.76M USD +23.4%
Operating Lease, Liability, Current 83K USD -36.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20K USD -66.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 85K USD -38.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3K USD -70%
Lessee, Operating Lease, Liability, to be Paid, Year Three 37K USD
Deferred Tax Assets, Operating Loss Carryforwards 11.3M USD +4.93%
Preferred Stock, Shares Issued 1K shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 168K USD -1.18%
Additional Paid in Capital 88.8M USD +1.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4K USD
Depreciation, Depletion and Amortization 63K USD +6.78%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%